share_log

基石藥業-B：於二零二四年一月十七日舉行之臨時股東大會之投票表決結果

CSTONE PHARMA-B: POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON JANUARY 17, 2024

香港交易所 ·  Jan 17 06:58
Summary by Moomoo AI
基石藥業-B於2024年1月17日召開的臨時股東大會上，股東以投票方式通過了一項普通決議案。該決議案涉及根據首次公開發售後僱員持股計劃向楊博士授出購股權，以認購合共14,000,000股股份。該決議案獲得超過50%的贊成票，其中贊成票為246,205,900票，反對票為57,631,303票，投票總數為303,837,203票。楊博士及其聯繫人放棄了對該決議案的表決權。臨時股東大會上有多位董事出席，包括李偉博士、楊建新博士等，而林向紅先生及Paul Herbert Chew博士因其他事務未能出席。香港中央證券登記有限公司被委任為監票員，以監察投票過程。
基石藥業-B於2024年1月17日召開的臨時股東大會上，股東以投票方式通過了一項普通決議案。該決議案涉及根據首次公開發售後僱員持股計劃向楊博士授出購股權，以認購合共14,000,000股股份。該決議案獲得超過50%的贊成票，其中贊成票為246,205,900票，反對票為57,631,303票，投票總數為303,837,203票。楊博士及其聯繫人放棄了對該決議案的表決權。臨時股東大會上有多位董事出席，包括李偉博士、楊建新博士等，而林向紅先生及Paul Herbert Chew博士因其他事務未能出席。香港中央證券登記有限公司被委任為監票員，以監察投票過程。
At the Extraordinary General Meeting held on January 17, 2024, the shareholders adopted an ordinary resolution by vote. The resolution involved the granting of a share option to Dr. Yang under the Employee Stock Ownership Scheme after the initial public offering to subscribe for a total of 14,000,000 shares. The resolution received over 50% in favor, with 246,205,900 votes in favor, 57,631,303 votes against, for a total of 303,837,203 votes. Dr. Yang and his contacts waived the vote on the resolution. The Extraordinary General Meeting was attended by a number of directors, including Dr. Li Wei, Dr. Yang Jianxin, etc., and Mr. Lin Shuanghong and Dr. Paul Herbert Chew were unable to attend due to other matters. The Central Securities Registry of Hong Kong Limited was appointed as a surveyor to monitor the voting process.
At the Extraordinary General Meeting held on January 17, 2024, the shareholders adopted an ordinary resolution by vote. The resolution involved the granting of a share option to Dr. Yang under the Employee Stock Ownership Scheme after the initial public offering to subscribe for a total of 14,000,000 shares. The resolution received over 50% in favor, with 246,205,900 votes in favor, 57,631,303 votes against, for a total of 303,837,203 votes. Dr. Yang and his contacts waived the vote on the resolution. The Extraordinary General Meeting was attended by a number of directors, including Dr. Li Wei, Dr. Yang Jianxin, etc., and Mr. Lin Shuanghong and Dr. Paul Herbert Chew were unable to attend due to other matters. The Central Securities Registry of Hong Kong Limited was appointed as a surveyor to monitor the voting process.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more